Research News

The tide is turning in a fifty-year war on a persistent strain of cholera, thanks to a team co-led by Tufts scientists and their research on the molecule cGAMP.

Tufts may be one of the smallest universities with a Clinical and Translational Science Award from the NIH, but it’s also especially adept at securing new partnerships beyond campus. Outlined here are three examples of exciting recent collaborations.

To be truly groundbreaking, a biomedical discovery needs to make a difference in the real world. That’s the premise driving translational science, a field that bridges gaps between research and clinical implementation.

Neuroscientist Klaus Miczek is working on stopping the brain system that creates a craving for alcohol and drugs in times of stress

Tufts researchers are testing bacteriophages—viruses that kill the cholera bacteria—as a way to halt the spread of the deadly disease.

A new study finds that two-father families still face discrimination, especially in states and settings that offer fewer legal and social protections.

What are the hidden health costs, though, that might not be reported immediately, but which are a result of a natural disaster?

Two Tufts alumni contributed to research providing a critical clue into the mysterious cause of the deadliest Ebola outbreak in history

Researchers from Tufts Public Health and the School of Engineering are investigating ways to improve indoor air quality in multifamily housing built near major roadways and highways.